“showed a trend”

A network meta-analysis in COPD patients showed a trend of SCC alone to be superior to usual care (OR 1.82, 95% CI 0.96–3.44; p=0.07) [ 59 ].

Serum uric acid decreased significantly (p = 0.012), while haemoglobin showed a trend towards improvement (p = 0.070).

Duration of Lenvatinib Treatment and Liver Function Maintenance Although there was no statistical difference in the duration of lenvatinib use between the two groups, the LRT group showed a trend toward longer treatment (p = 0.07).

All litters had lower ( p < 0.05) plasma IFNγ concentration on D63 compared to D0 except Litter 269–2F ( n = 8), which only showed a trend ( p = 0.07) toward decreased plasma IFNγ concentrations ( Figure 3C ).

Serum corticosterone was not affected by OVX but OVX + E2 showed a trend toward a lower concentration relative to sham and OVX (p = 0.07).

Size and percentage of T2LIA showed a trend towards association with survival ( p = 0.07 and 0.05, respectively).

Diabetes mellitus showed a trend towards increased risk without reaching statistical significance (OR 1.50, 95% CI 0.97–2.33, p = 0.070).

In contrast, posterior (and middle) hippocampal encoding engagement showed a trend-level relationship with later true recognitions across age groups (effect of engagement: β=0.05, SE=0.03, Z = 1.81, p = 0.07) in a way that reliably varied by encoding condition (engagement × encoding condition interaction: β=0.06, SE=0.03, Z = 2.27, p = 0.02; no interactions with age group: both p > 0.77; Fig. 3 A ).

While IGHJ4 gene usage was not associated with significant differences in prognosis (p = 0.37; Figure 2D ), patients harboring IGHJ6 gene showed a trend towards inferior five-years RFS (p = 0.07; Figure 2E ).

The low physical function group showed a trend toward a stronger correlation compared to the high physical function group ( z = 1.81, P = 0.070) and a significant stronger correlation compared to the younger group ( z = 2.13, P = 0.033). 3.5.

In line with these findings, individuals with high HbA1c levels (≥7.5%) showed a trend for higher weight loss (p = 0.07; Supplemental Figure S3F ).

Family-based association TDT analysis of n = 448 trio CHD families showed a trend for rs1805087 in cyanotic cases ( p = 0.07), particularly driven by TOF ( p = 0.09), with preferential maternal allele transmissions ( p = 0.01, p = 0.05) in the same groups.

The superficial motor cortex showed a trend toward increased percent area of CD31+ blood vessels in NA‐CI mice (3.97% ± 1.15%, n = 9) compared to NA‐PBS mice (3.16% ± 0.81%, n = 7, p ≤ 0.07; Figure 4B ).

Survival BMI groups showed a trend to predict survival in our study cohort (p = 0.07, Fig. 2 ).

EVs from unstimulated control ChPE cells showed a trend ( P = 0.07) of increased uptake following hIGF-1 stimulation (Fig. 5 F).

The mOS was similar for all genotypes in the PANGEA cohort, while the non-PANGEA cohort showed a trend towards prolonged survival in the non-F/F subgroup (mOS 43.4 versus 23.1 months, P = 0.07; Figure 2 A-C; Table 2 ).

While there was no significant difference in reducing overall disability compared to no thrombolysis, the effect estimate showed a trend favoring Tenecteplase (gOR 1.28, CI 0.98–1.67; p = 0.07; I 2 = 0%) ( Figure 3 ). 4.

lenta –gavaged mice showed a trend toward reduced levels of fecal butyrate, a SCFA ( Fig. 5A ; P = 0.07).

Spearman correlation showed a trend between word reading test speed and scholastic TMA ( p = 0.07) in the experimental group ( Figure 1 ).

Non-compliance with follow-up showed a trend toward decreased survival ( P = 0.07).

FMT significantly upregulated the expression of Claudin-1 and MUC2 ( P < 0.05) and showed a trend toward increased ZO-2 ( P = 0.07; Fig. 3 F).

Analyses 14 days after reinfusion showed a trend (p=0.07) for higher total CD3+ counts with a median of 724x10 6 /L in responders compared to 182x10 6 /L in non-responders, count of CD3+ CAR cells with 105x10 6 /L and 14x10 6 /L (p=0.07) as well as CD3+/CD4+ cells with 291x10 6 /L and 70x10 6 /L, respectively, (p=0.10).

Notably, serum cholesterol levels showed a trend of decreasing in response to losartan ( p = 0.07) and mirabegron ( p = 0.08) compared to the DOXO-only group ( Table 2 ).

In the treated‐untreated comparison, the treated group showed a trend toward slower increases in CDR‐SB scores post‐treatment (ΔT=‐1.8, p = 0.07) compared to the untreated group (Figure 2).

IL-7 levels showed a trend to be predictive for progressive and end-stage diseases compared with constant controls ( P = 0.07 and P = 0.09, respectively).